Nadeen Zerafa

3.0k total citations · 1 hit paper
20 papers, 2.3k citations indexed

About

Nadeen Zerafa is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Nadeen Zerafa has authored 20 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Public Health, Environmental and Occupational Health and 7 papers in Immunology. Recurrent topics in Nadeen Zerafa's work include Reproductive Biology and Fertility (10 papers), Immune Cell Function and Interaction (6 papers) and Pluripotent Stem Cells Research (4 papers). Nadeen Zerafa is often cited by papers focused on Reproductive Biology and Fertility (10 papers), Immune Cell Function and Interaction (6 papers) and Pluripotent Stem Cells Research (4 papers). Nadeen Zerafa collaborates with scholars based in Australia, United States and Italy. Nadeen Zerafa's co-authors include Mark J. Smyth, Jeremy B. Swann, Robert D. Schreiber, Lloyd J. Old, William Vermi, Catherine Koebel, Scott J. Rodig, Yoshihiro Hayakawa, Erika Cretney and Karla J. Hutt and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Nadeen Zerafa

20 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adaptive immunity maintains occult cancer in an equilibrium state

2007 1.0k citations Catherine Koebel, William Vermi et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadeen Zerafa Australia	13	1.3k	1.1k	598	367	231	20	2.3k
Abdeljabar El Andaloussi United States	19	812 0.6×	494 0.5×	540 0.9×	174 0.5×	178 0.8×	36	1.7k
Wendy K. Nevala United States	23	810 0.6×	705 0.7×	624 1.0×	165 0.4×	142 0.6×	67	1.8k
Koji Aoki Japan	20	780 0.6×	350 0.3×	947 1.6×	384 1.0×	202 0.9×	42	2.1k
Tateki Tsutsui Japan	24	495 0.4×	466 0.4×	603 1.0×	225 0.6×	98 0.4×	59	1.8k
Fusanori Yotsumoto Japan	26	373 0.3×	473 0.4×	750 1.3×	190 0.5×	268 1.2×	75	1.6k
Peter Mottram United States	11	1.9k 1.4×	1.2k 1.1×	404 0.7×	47 0.1×	154 0.7×	13	2.4k
Hilary J. McKenna Canada	16	1.9k 1.4×	600 0.6×	685 1.1×	126 0.3×	70 0.3×	20	2.6k
Linhua Vatan United States	9	1.8k 1.4×	1.1k 1.0×	355 0.6×	51 0.1×	149 0.6×	10	2.3k
Julie A. DeLoia United States	30	670 0.5×	812 0.8×	1.2k 2.1×	412 1.1×	428 1.9×	63	2.9k
Annikki Liakka Finland	16	423 0.3×	249 0.2×	376 0.6×	184 0.5×	171 0.7×	24	1.3k

Countries citing papers authored by Nadeen Zerafa

Since Specialization

Citations

This map shows the geographic impact of Nadeen Zerafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadeen Zerafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadeen Zerafa more than expected).

Fields of papers citing papers by Nadeen Zerafa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadeen Zerafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadeen Zerafa. The network helps show where Nadeen Zerafa may publish in the future.

Co-authorship network of co-authors of Nadeen Zerafa

This figure shows the co-authorship network connecting the top 25 collaborators of Nadeen Zerafa. A scholar is included among the top collaborators of Nadeen Zerafa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadeen Zerafa. Nadeen Zerafa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winship, Amy, Jessica M. Stringer, Yujie Cao, et al.. (2024). Conditional loss of Brca1 in oocytes causes reduced litter size, ovarian reserve depletion and impaired oocyte in vitro maturation with advanced reproductive age in mice. EBioMedicine. 106. 105262–105262. 1 indexed citations

Merriner, D. Jo, Brendan J. Houston, Moira K. O’Bryan, et al.. (2023). Impact of Chronic Multi-Generational Exposure to an Environmentally Relevant Atrazine Concentration on Testicular Development and Function in Mice. Cells. 12(4). 648–648. 8 indexed citations

Lyu, Ruqian, Jessica M. Stringer, Jessica E. M. Dunleavy, et al.. (2023). Fancm has dual roles in the limiting of meiotic crossovers and germ cell maintenance in mammals. Cell Genomics. 3(8). 100349–100349. 7 indexed citations

Cai, Xue‐Bi, Jessica M. Stringer, Nadeen Zerafa, John Carroll, & Karla J. Hutt. (2023). Xrcc5/Ku80 is required for the repair of DNA damage in fully grown meiotically arrested mammalian oocytes. Cell Death and Disease. 14(7). 397–397. 8 indexed citations

Zerafa, Nadeen, et al.. (2023). Xrcc5/KU80 is not required for the survival or activation of prophase-arrested oocytes in primordial follicles. Frontiers in Endocrinology. 14. 1268009–1268009. 3 indexed citations

Winship, Amy, Sneha Sant, Jessica M. Stringer, et al.. (2022). Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice. Nature Cancer. 3(8). 1–13. 58 indexed citations

Nguyen, Quynh‐Nhu, Nadeen Zerafa, Jock K. Findlay, Martha Hickey, & Karla J. Hutt. (2021). DNA repair in primordial follicle oocytes following cisplatin treatment. Journal of Assisted Reproduction and Genetics. 38(6). 1405–1417. 12 indexed citations

Stringer, Jessica M., Amy Winship, Nadeen Zerafa, Matthew J. Wakefield, & Karla J. Hutt. (2020). Oocytes can efficiently repair DNA double-strand breaks to restore genetic integrity and protect offspring health. Proceedings of the National Academy of Sciences. 117(21). 11513–11522. 85 indexed citations

Nguyen, Quynh‐Nhu, Nadeen Zerafa, Seng H. Liew, et al.. (2019). Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes. Molecular Human Reproduction. 25(8). 433–444. 93 indexed citations

10.

Nguyen, Quynh-Nhu, Nadeen Zerafa, Seng H. Liew, et al.. (2018). Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility. Cell Death and Disease. 9(6). 618–618. 103 indexed citations

11.

Stringer, Jessica M., et al.. (2018). Multidose 5-Fluorouracil is Highly Toxic to Growing Ovarian Follicles in Mice. Toxicological Sciences. 166(1). 97–107. 20 indexed citations

12.

Liew, Seng H., Nadeen Zerafa, Michele Cook, et al.. (2016). BCL2-modifying factor promotes germ cell loss during murine oogenesis. Reproduction. 151(5). 553–562. 11 indexed citations

13.

Myers, Michelle, Seng H. Liew, Nadeen Zerafa, et al.. (2014). PUMA regulates germ cell loss and primordial follicle endowment in mice. Reproduction. 148(2). 211–219. 44 indexed citations

14.

Teng, Michele W.L., Jeremy B. Swann, Bianca von Scheidt, et al.. (2010). Multiple Antitumor Mechanisms Downstream of Prophylactic Regulatory T-Cell Depletion. Cancer Research. 70(7). 2665–2674. 58 indexed citations

15.

Street, Shayna E.A., Nadeen Zerafa, Manuela Iezzi, et al.. (2007). Host Perforin Reduces Tumor Number but Does Not Increase Survival in Oncogene-Driven Mammary Adenocarcinoma. Cancer Research. 67(11). 5454–5460. 39 indexed citations

16.

Swann, Jeremy B., Yoshihiro Hayakawa, Nadeen Zerafa, et al.. (2007). Type I IFN Contributes to NK Cell Homeostasis, Activation, and Antitumor Function. The Journal of Immunology. 178(12). 7540–7549. 262 indexed citations

17.

Koebel, Catherine, William Vermi, Jeremy B. Swann, et al.. (2007). Adaptive immunity maintains occult cancer in an equilibrium state. Nature. 450(7171). 903–907. 1024 indexed citations breakdown →

18.

Smyth, Mark J., Yoshihiro Hayakawa, Erika Cretney, et al.. (2006). IL-21 Enhances Tumor-Specific CTL Induction by Anti-DR5 Antibody Therapy. The Journal of Immunology. 176(10). 6347–6355. 33 indexed citations

19.

Smyth, Mark J., Jeremy B. Swann, Erika Cretney, et al.. (2005). NKG2D function protects the host from tumor initiation. The Journal of Experimental Medicine. 202(5). 583–588. 261 indexed citations

20.

Zerafa, Nadeen, Jennifer A. Westwood, Erika Cretney, et al.. (2005). Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies. The Journal of Immunology. 175(9). 5586–5590. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact